A significant advance in cancer investigation is emerging with the use of mini-antibodies to re-engage mutated p53. This vital malignant inhibitor protein is frequently inactivated in several kinds of tumors, leading https://seobookmarkpro.com/story21971771/mini-antibodies-revive-tumor-suppressor-p53-the-potential-approach-for-malignant-treatment